Literature DB >> 15847354

Epidemic of leptospirosis: an ICU experience.

V Chawla1, T H Trivedi, M E Yeolekar.   

Abstract

AIMS: To study the clinical profile and outcome of critically ill patients suffering from leptospirosis with organ dysfunction and correlate mortality with individual risk factors.
METHODS: A study of critically ill patients suffering from leptospirosis was carried out in the Medical Intensive Care Unit of a tertiary centre of a metropolitan city between 1st June 2002 and 31st May 2003. All the patients in whom diagnosis was confirmed by ELISA IgM antibody testing underwent thorough clinical examination and necessary biochemical investigations. They received standard antimicrobial therapy and extensive supportive therapy as required. Mortality was correlated with individual risk factors.
RESULTS: Out of 834 total admissions in this period, 60 (7.2%) patients suffered from leptospirosis. There were 48 males and 12 females with age ranging from 12 to 60 years, mean age being 40 years. The clinical manifestations varied from fever (58 patients), jaundice (38), subconjunctival haemorrhages (24), to altered sensorium (22). All the patients had evidence of severe sepsis. Forty six patients had multiple organ dysfunction syndrome (MODS) and 26 required ventilatory support. The total mortality in leptospirosis patients was 52% which was much higher compared to the total MICU mortality (31.4%) in the same period.
CONCLUSION: Leptospirosis is an important infection associated with high mortality when associated with organ dysfunction. The poor prognostic factors are preponderance of male sex, alcohol dependence, age group > 50 years, MODS, acute respiratory distress syndrome (ARDS), presence of acidosis and need for mechanical ventilation. However, timelyintervention and intensive therapy can save many young lives.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15847354

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  23 in total

Review 1.  Whole-cell inactivated leptospirosis vaccine: future prospects.

Authors:  Ramesh Verma; Pardeep Khanna; Suraj Chawla
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

2.  Determinants of mortality and impact of therapy in patients with leptospirosis admitted for intensive care in a Sri Lankan hospital--a three year retrospective study.

Authors:  P N Weeratunga; S Fernando; S Sriharan; M Gunawardena; S Wijenayake
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

3.  Does leptospirosis behave adversely in cirrhosis of the liver?

Authors:  Aravindh Somasundaram; Nattusamy Loganathan; Joy Varghese; Singh Shivakumar; Venkataraman Jayanthi
Journal:  Indian J Gastroenterol       Date:  2014-09-21

4.  Pulmonary leptospirosis: an excellent response to bolus methylprednisolone.

Authors:  V V Shenoy; V S Nagar; A A Chowdhury; P S Bhalgat; N I Juvale
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

5.  Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis.

Authors:  Samir V Trivedi; Ashwin H Vasava; Tinkal C Patel; Lovleen C Bhatia
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun

6.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

7.  Comparison between early and delayed acute kidney injury secondary to infectious disease in the intensive care unit.

Authors:  Rafael S A Lima; Cristina N Marques; Geraldo B Silva Júnior; Aline S Barbosa; Eveline S Barbosa; Rosa M S Mota; Sônia M H A Araújo; Oswaldo A Gutiérrez-Adrianzén; Alexandre B Libório; Elizabeth F Daher
Journal:  Int Urol Nephrol       Date:  2008-03-27       Impact factor: 2.370

8.  Leptospirosis: a globally increasing zoonotic disease.

Authors:  Clare Rock; Deirdre Brady; Patrick Forde; Patricia Lucey; Mary Horgan
Journal:  BMJ Case Rep       Date:  2010-11-05

9.  Commonly used severity scores are not good predictors of mortality in sepsis from severe leptospirosis: a series of ten patients.

Authors:  Dimitrios Velissaris; Menelaos Karanikolas; Nikolaos Flaris; Fotini Fligou; Markos Marangos; Kriton S Filos
Journal:  Crit Care Res Pract       Date:  2012-05-21

10.  Low serum total nitrite and nitrate levels in severe leptospirosis.

Authors:  Thilini Kalugalage; Chaturaka Rodrigo; Thamal Vithanage; Pranitha Somaratne; H Janaka De Silva; Shiroma Handunnetti; Senaka Rajapakse
Journal:  BMC Infect Dis       Date:  2013-05-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.